Correlation Between Sharps Technology and Sunshine Biopharma
Can any of the company-specific risk be diversified away by investing in both Sharps Technology and Sunshine Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sharps Technology and Sunshine Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sharps Technology Warrant and Sunshine Biopharma Warrant, you can compare the effects of market volatilities on Sharps Technology and Sunshine Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sharps Technology with a short position of Sunshine Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sharps Technology and Sunshine Biopharma.
Diversification Opportunities for Sharps Technology and Sunshine Biopharma
-0.15 | Correlation Coefficient |
Good diversification
The 3 months correlation between Sharps and Sunshine is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Sharps Technology Warrant and Sunshine Biopharma Warrant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sunshine Biopharma and Sharps Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sharps Technology Warrant are associated (or correlated) with Sunshine Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sunshine Biopharma has no effect on the direction of Sharps Technology i.e., Sharps Technology and Sunshine Biopharma go up and down completely randomly.
Pair Corralation between Sharps Technology and Sunshine Biopharma
Assuming the 90 days horizon Sharps Technology Warrant is expected to under-perform the Sunshine Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Sharps Technology Warrant is 1.86 times less risky than Sunshine Biopharma. The stock trades about -0.15 of its potential returns per unit of risk. The Sunshine Biopharma Warrant is currently generating about 0.32 of returns per unit of risk over similar time horizon. If you would invest 7.70 in Sunshine Biopharma Warrant on August 28, 2024 and sell it today you would earn a total of 14.30 from holding Sunshine Biopharma Warrant or generate 185.71% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 86.36% |
| Values | Daily Returns |
Sharps Technology Warrant vs. Sunshine Biopharma Warrant
Performance |
| Timeline |
| Sharps Technology Warrant |
| Sunshine Biopharma |
Sharps Technology and Sunshine Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sharps Technology and Sunshine Biopharma
The main advantage of trading using opposite Sharps Technology and Sunshine Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sharps Technology position performs unexpectedly, Sunshine Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sunshine Biopharma will offset losses from the drop in Sunshine Biopharma's long position.| Sharps Technology vs. Sharps Technology | Sharps Technology vs. Tenon Medical | Sharps Technology vs. Scisparc | Sharps Technology vs. OKYO Pharma Ltd |
| Sunshine Biopharma vs. Sunshine Biopharma | Sunshine Biopharma vs. Thayer Ventures Acquisition | Sunshine Biopharma vs. Biofrontera Warrants | Sunshine Biopharma vs. Neurosense Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |